Carbapenemase production among less-common Enterobacterales genera: 10 US sites, 2018
Supporting Files
Public Domain
-
9 04 2021
-
Available in CDC Stacks on 2021-09-04T00:00:00Z
File Language:
English
Details
-
Alternative Title:JAC Antimicrob Resist
-
Personal Author:Shugart, Alicia ; Mahon, Garrett ; Huang, Jennifer Y ; Karlsson, Maria ; Valley, Ann ; Lasure, Megan ; Gross, Annastasia ; Pattee, Brittany ; Vaeth, Elisabeth ; Brooks, Richard ; Maruca, Tyler ; Dominguez, Catherine E ; Torpey, David ; Francis, Drew ; Bhattarai, Rachana ; Kainer, Marion A ; Chan, Allison ; Dubendris, Heather ; Greene, Shermalyn R ; Blosser, Sara J ; Shannon, D J ; Jones, Kelly ; Brennan, Brenda ; Hun, Sopheay ; D’Angeli, Marisa ; Murphy, Caitlin N ; Tierney, Maureen ; Reese, Natashia ; Bhatnagar, Amelia ; Kallen, Alex ; Brown, Allison C ; Spalding Walters, Maroya
-
Description:Background ; Historically, United States’ carbapenem-resistant Enterobacterales (CRE) surveillance and mechanism testing focused on three genera: Escherichia, Klebsiella, and Enterobacter (EsKE); however, other genera can harbour mobile carbapenemases associated with CRE spread. ; Objectives ; From January through May 2018, we conducted a 10 state evaluation to assess the contribution of less common genera (LCG) to carbapenemase-producing (CP) CRE. ; Methods ; State public health laboratories (SPHLs) requested participating clinical laboratories submit all Enterobacterales from all specimen sources during the surveillance period that were resistant to any carbapenem (Morganellaceae required resistance to doripenem, ertapenem, or meropenem) or were CP based on phenotypic or genotypic testing at the clinical laboratory. SPHLs performed species identification, phenotypic carbapenemase production testing, and molecular testing for carbapenemases to identify CP-CRE. Isolates were categorized as CP if they demonstrated phenotypic carbapenemase production and ≥1 carbapenemase gene (blaKPC, blaNDM, blaVIM, blaIMP, or blaOXA-48-like) was detected. ; Results ; SPHLs tested 868 CRE isolates, 127 (14.6%) were from eight LCG. Overall, 195 (26.3%) EsKE isolates were CP-CRE, compared with 24 (18.9%) LCG isolates. LCG accounted for 24 (11.0%) of 219 CP-CRE identified. Citrobacter spp. was the most common CP-LCG; the proportion of Citrobacter that were CP (11/42, 26.2%) was similar to the proportion of EsKE that were CP (195/741, 26.3%). Five of 24 (20.8%) CP-LCG had a carbapenemase gene other than blaKPC. ; Conclusions ; Participating sites would have missed approximately 1 in 10 CP-CRE if isolate submission had been limited to EsKE genera. Expanding mechanism testing to additional genera could improve detection and prevention efforts.
-
Subjects:
-
Source:JAC Antimicrob Resist. 2021; 3(3)
-
Pubmed ID:34514407
-
Pubmed Central ID:PMC8417453
-
Document Type:
-
Volume:3
-
Issue:3
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha256:d952f630bb2c00b62976f6d003a7083e07b5f4b56812e2f46c0f83fb70ad4ada
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access